NCT00109486已完成3 期
A Randomised, Double-Blind, Placebo-Controlled, Two-Week Crossover, Knemometric Assessment of the Effect of Fluticasone Furoate Nasal Spray 100mcg Once Daily on Short-Term Growth in Children Aged 6 to 11 Years With Seasonal and/or Perennial Allergic Rhinitis
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 56
- 试验地点
- 1
- 主要终点
- The primary safety endpoint will be the mean growth velocity (mm/wk) in lower leg growth, as determined by knemometry, over a 2-week treatment period with intranasal GW685698X aqueous nasal spray versus a 2-week treatment with placebo nasal spray.
研究概览
简要总结
The purpose of this study is to assess any effect in children with seasonal and/or perennial allergic rhinitis by GW685698X aqueous nasal spray (versus vehicle placebo nasal spray) on growth using knemometry.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 6 Years 至 12 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Arm 1
Experimental
干预措施: GW685698X (Drug)
结局指标
主要结局
The primary safety endpoint will be the mean growth velocity (mm/wk) in lower leg growth, as determined by knemometry, over a 2-week treatment period with intranasal GW685698X aqueous nasal spray versus a 2-week treatment with placebo nasal spray.
次要结局
- Secondary endpoints will include the frequency and type of clinical adverse events (AEs) experienced during treatment, nasal examinations, vital signs (systolic and diastolic blood pressure, heart rate [pulse]).
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)Seasonal Allergic RhinitisNCT00358527Organon and Co401
已完成
2 期
Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberRhinitis, Allergic, SeasonalSeasonal Allergic RhinitisNCT00430157GlaxoSmithKline45
已完成
不适用
Probiotics in Paediatric Asthma ManagementAsthma in ChildrenNCT04289441Probiotical S.p.A.46
已完成
2 期
Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberRhinitis, Allergic, SeasonalSeasonal Allergic RhinitisNCT00377728GlaxoSmithKline44
已完成
2 期
Efficacy and Safety Study of BLX-028914 in Subjects With Allergic RhinitisAllergic RhinitisNCT00758446Dart NeuroScience, LLC36